Article
Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours.
European journal of cancer (Oxford, England : 1990) - 1 Dec 1996
Milner B J, Hosking L, Sun S, Haites N E, Foulkes W D
Abstract excerpt
In breast cancers and sarcomas, a variant polymorphism in the cell cycle inhibitor P21CIP1/WAF1 is under-represented in those individuals whose tumours contain mutated TP53. The aim of this study was to determine whether this variant polymorphism was also under-represented in those with ovarian carcinoma and TP53 mutations. We studied lymphocyte DNA from 104 women with ovarian carcinoma, 15 with borderline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
